IRIS
LUISETTI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.568
EU - Europa 3.152
AS - Asia 2.182
OC - Oceania 15
AF - Africa 10
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.550
CN - Cina 2.067
IE - Irlanda 919
UA - Ucraina 771
FI - Finlandia 457
DE - Germania 417
SE - Svezia 244
GB - Regno Unito 126
IT - Italia 103
SG - Singapore 55
FR - Francia 49
BE - Belgio 30
CA - Canada 18
AU - Australia 14
IR - Iran 13
JP - Giappone 11
RU - Federazione Russa 10
CZ - Repubblica Ceca 7
HK - Hong Kong 7
IN - India 7
TW - Taiwan 7
EU - Europa 5
NL - Olanda 5
PK - Pakistan 5
BR - Brasile 4
CL - Cile 4
EG - Egitto 4
KR - Corea 4
MU - Mauritius 3
PL - Polonia 3
PT - Portogallo 3
TR - Turchia 3
AR - Argentina 2
AT - Austria 2
ES - Italia 2
LV - Lettonia 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
GR - Grecia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
ZA - Sudafrica 1
Totale 9.942
Salva come PNG Salva come JPEG
Città #
Jacksonville 954
Chandler 927
Dublin 918
Nanjing 640
Boardman 305
Ashburn 278
Nanchang 230
Princeton 199
Lawrence 192
Shenyang 190
Wilmington 170
Hebei 163
Changsha 152
Beijing 150
Ann Arbor 147
Jiaxing 147
Medford 101
Hangzhou 98
Helsinki 87
Tianjin 86
Shanghai 66
Woodbridge 51
Norwalk 37
Milan 36
Singapore 36
Brussels 30
Falls Church 28
Houston 28
Piscataway 26
Fairfield 25
Kunming 25
New York 25
Washington 25
Verona 23
Des Moines 20
Dearborn 19
Seattle 19
Tappahannock 17
Los Angeles 14
Changchun 9
Pavia 9
Fuzhou 8
Jinan 8
Auburn Hills 7
Lanzhou 7
Ningbo 7
Orange 7
Taizhou 7
Toronto 7
Zhengzhou 7
Tokyo 6
Berlin 5
Brisbane 5
Novara 5
Rome 5
San Francisco 5
Teplice 5
Karachi 4
Ottawa 4
Pune 4
Boston 3
Chicago 3
Honchō 3
Leawood 3
Lewiston 3
Lisbon 3
Melbourne 3
Montreal 3
New Taipei City 3
Novokuznetsk 3
Oakville 3
Redwood City 3
Santiago 3
Sydney 3
Taoyuan District 3
Tomsk 3
Alexandria 2
Aversa 2
Birmingham 2
Borås 2
Cairo 2
Corsico 2
Dallas 2
Durham 2
Falkenstein 2
Frankfurt am Main 2
Frisco 2
Karaj 2
Lagos 2
London 2
Manchester 2
Marlton 2
Munich 2
Nantes 2
Naples 2
Paraná 2
Portland 2
Raleigh 2
Ribeirão Preto 2
San Jose 2
Totale 6.911
Salva come PNG Salva come JPEG
Nome #
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. 201
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 157
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 120
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 89
Familial elevation of serum angiotensin converting enzyme activity. 89
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 88
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 88
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. 84
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 83
Advances in proteomic techniques for biomarker discovery in COPD 82
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 77
A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. 74
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 74
Studies of MR 889, a new synthetic proteinase inhibitor. 73
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 72
α₁-Antitrypsin level and pheno/genotypes 72
Identification and characterisation of eight novel SERPINA1 null mutations. 72
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 71
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. 71
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. 70
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. 70
Some properties of the alkaline proteinase from Aspergillus melleus. 70
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. 68
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. 68
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. 67
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 67
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. 67
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. 67
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 66
Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. 65
Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. 65
Assessment and management of pulmonary alveolar proteinosis in a reference center. 65
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 64
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 64
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 63
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 63
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 62
Alpha-1 antitrypsin deficiency: from Italy to the world. 62
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 62
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 61
HLA markers in sarcoidosis. 61
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. 61
HLA and sarcoidosis: new pathogenetic insights. 60
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 59
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 59
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. 59
On the activity of MR 889, a new synthetic proteinase inhibitor. 59
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. 59
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 59
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 58
Complement receptor 1 gene polymorphisms in sarcoidosis. 58
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 58
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 58
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 57
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. 57
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 57
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 57
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 56
Mechanisms of lung injury in cystic fibrosis. 56
Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose. 56
HLA Class I, II and III polymorphisms in sarcoidosis. 56
Lung cancer in young adults. 56
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 56
Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis. 56
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 56
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. 55
Genetics of idiopathic disseminated bronchiectasis. 55
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 55
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. 55
A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. 55
COPD: no gene left unturned 55
In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation. 55
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. 55
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 54
Genetics of chronic obstructive pulmonary disease and disseminated bronchiectasis. 54
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 54
Report of one case of familial sarcoidosis. 54
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 54
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 53
Introduction: the history of the Alpha One International Registry (A.I.R.). 53
Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. 53
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 53
Sarcoidosis of the thyroid: report of a case and a review of the literature. 52
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. 52
Biochemical and functional markers of lung damage after bleomycin treatment. 52
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 52
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. 52
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. 52
High performance capillary electrophoresis in the study of proteinase activity and of markers of lung destruction. 51
Clinical utility gene card for: α-1-antitrypsin deficiency. 51
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 51
Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. 51
Primary lung adenocarcinoma: characteristics by smoking habit and sex. 51
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 51
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 51
Mapping the activities of secretory leukoprotease inhibitor. 50
Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. 50
Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. 50
Comment on 'CFTR gene mutations in sarcoidosis'. 50
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 50
Totale 6.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.948 0 991 40 185 42 174 18 175 15 186 120 2
2020/20211.415 179 141 42 152 3 182 11 220 38 215 191 41
2021/2022727 18 5 5 16 17 26 22 60 49 10 126 373
2022/20232.658 284 184 19 225 319 276 0 153 1.061 22 71 44
2023/2024955 102 180 43 67 109 199 14 50 8 68 73 42
2024/2025294 80 214 0 0 0 0 0 0 0 0 0 0
Totale 10.019